colon cancer
Conditions
Interventions
one time
forty-six hours
Sponsors
Kobe City Medical center General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients had newly diagnosed and histologically confirmed colorectal cancer 2. Patients were age 20 years or older 3. Eastern Cooperative Oncology Group performance status of 0-2 4. Patients receive chemotherapy including FOLFOX or FOLFIRI regimen using pressure type pump in outpatient setting. 5. Adequate hematologic, hepatic and renal function as follows: Neutrophil count 1,500/mm^3or higher Haemoglobin level 9.0g/dl or higher Platelet count 100,000/mm^3 or higher Serum Total bilirubin level 1.0x the upper limit of normal or lower Serum aspartate aminotransferase (AST) levels no higher than 1.5 the ULN Serum alanine aminotransferase (ALT) levels no higher than 1.5 the ULN Serum creatinine level no higher than 1.5 the ULN Or Creatinine clearance 50ml/min or higher 6. All patients provided written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with active infection 2. Patients with severe pulmonary disease 3. Patients with uncontrolled heart disease 4. Patients for whom it's difficult to handle a instrument
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A cross-comparative analysis of VESSEL FUSER (type T) with conventional type (Safety, QOL, filling ability of drug, safety of drug flow, injecting time, priming time, compatibility to other instruments) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of patient Quality of life Reduction in nursing work Reduction in liquid medicine filling time Cost reduction | — |
Countries
Japan
Contacts
Public ContactYukimasa Hatachi
Kobe City Medical center General Hospital Medical Oncology
Outcome results
None listed